An open label, single arm, investigator initiated Phase I/II study to assess the safety and efficacy of local administration of stempeucel (Adult Human Bone Marrow Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells) in Patients with Perianal Fistulizing Crohn's disease
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Crohn's disease; Rectal fistula
- Focus Adverse reactions
- 18 Jun 2020 New trial record